Geneva Partners’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
Geneva Partners's ORCL Position: Q1 2025 in Review
Geneva Partners sold out of Oracle (ORCL) in Q1 2025, closing a stake of 30,060 shares — an estimated $5.01M sold.
Geneva Partners first reported a position in ORCL in Q2 2023 and held it in 3 quarters. The position peaked at $5.01M in Q4 2024. 3,246 funds tracked by Wall St. Rank hold ORCL as of Q1 2025.
- Geneva Partners reported no remaining Oracle position as of Q1 2025 after selling out during the quarter.
- Geneva Partners sold 30,060 Oracle shares in Q1 2025, an estimated $5.01M.
- Geneva Partners first reported a position in Oracle in Q2 2023 and held it in 3 quarters.
- Geneva Partners's Oracle position peaked at $5.01M in Q4 2024.
- 3,246 funds tracked by Wall St. Rank held Oracle as of Q1 2025.
Based on Geneva Partners's 13F filing for Q1 2025, filed 30 Apr 2025.